These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32396603)

  • 1. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

  • 2. How did COVID-19 pandemic changed the Portuguese rheumatology?
    Vieira-Sousa E; Fonseca JE; Santos MJ
    Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820
    [No Abstract]   [Full Text] [Related]  

  • 3. Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.
    Tam LS; Tanaka Y; Handa R; Chang CC; Cheng YK; Isalm N; Li M; Lorenzo JP; Song YW; Yamamoto K; Zeng X; Haq SA
    Int J Rheum Dis; 2020 Jun; 23(6):717-722. PubMed ID: 32462761
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
    Morales-Torres J; Aceves-Ávila FJ
    Clin Rheumatol; 2020 Nov; 39(11):3177-3183. PubMed ID: 32889590
    [No Abstract]   [Full Text] [Related]  

  • 5. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.
    Robinson PC; Yazdany J
    Nat Rev Rheumatol; 2020 Jun; 16(6):293-294. PubMed ID: 32242121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic.
    Masini F; Gjeloshi K; Ferrara R; Pinotti E; Cuomo G
    Rheumatol Int; 2020 Sep; 40(9):1537-1538. PubMed ID: 32666135
    [No Abstract]   [Full Text] [Related]  

  • 7. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments].
    Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Krüger K
    Z Rheumatol; 2020 Sep; 79(7):686-691. PubMed ID: 32845393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic.
    Schulze-Koops H; Specker C; Iking-Konert C; Holle J; Moosig F; Krueger K
    Ann Rheum Dis; 2020 Jun; 79(6):840-842. PubMed ID: 32345619
    [No Abstract]   [Full Text] [Related]  

  • 9. How and why are rheumatologists relevant to COVID-19?
    Felten R; Chatelus E; Arnaud L
    Joint Bone Spine; 2020 Jul; 87(4):279-280. PubMed ID: 32451147
    [No Abstract]   [Full Text] [Related]  

  • 10. How to manage rheumatic patients during the coronavirus pandemic.
    Parisi S; Ditto MC; Finucci A; Fusaro E
    Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the Impact of COVID-19 in Latin America.
    Bautista-Molano W; Ferreyra Garrot L; Toro C;
    J Clin Rheumatol; 2020 Sep; 26(6):218-219. PubMed ID: 32852926
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.
    Kim HS; Lee MS; Kim H; Sung YK; Lee J; Shim SC; Park SH; Baek HJ
    Rheumatol Int; 2020 Aug; 40(8):1347-1349. PubMed ID: 32488428
    [No Abstract]   [Full Text] [Related]  

  • 13. #Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic.
    Ruffer N; Knitza J; Krusche M
    Rheumatol Int; 2020 Dec; 40(12):2031-2037. PubMed ID: 32995894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How diabetes management is adapting amid the COVID-19 pandemic.
    Ranscombe P
    Lancet Diabetes Endocrinol; 2020 Jul; 8(7):571. PubMed ID: 32422126
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Clinical trial design in the era of COVID-19.
    Begg CB; Gonen M; Heitjan DF
    Clin Trials; 2020 Oct; 17(5):465-466. PubMed ID: 32650671
    [No Abstract]   [Full Text] [Related]  

  • 16. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.
    Wallace ZS; Bhana S; Hausmann JS; Robinson PC; Sufka P; Sirotich E; Yazdany J; Grainger R
    Rheumatology (Oxford); 2020 Jun; 59(6):1204-1206. PubMed ID: 32374851
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of Rheumatic Diseases during the COVID-19 Pandemic: Beyond Telehealth Services].
    Fernandes AL; Silva C; Miranda LC
    Acta Med Port; 2020 Oct; 33(10):706. PubMed ID: 32840207
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19: a primer for the rheumatologist: management of patients and care settings.
    Calabrese C; Lehman B
    Curr Opin Rheumatol; 2020 Sep; 32(5):429-433. PubMed ID: 32744823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and Management of COVID-19 Disease.
    Jamil S; Mark N; Carlos G; Cruz CSD; Gross JE; Pasnick S
    Am J Respir Crit Care Med; 2020 May; 201(10):P19-P20. PubMed ID: 32223716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.